IFNG and cancer: The inhibitory effect of recombinant IFN-γ has been demonstrated against several viruses (Parvez et al., 2006; Wang et al., 2014; Busnadiego et al., 2020) and cancer cells (Razaghi et al., 2017; Shen et al., 2018).